Skip to main content

Advertisement

SpringerLink
Log in

Perimenstrual headaches: Unmet needs

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

The risk of migraine is increased among women during a 5-day perimenstrual window that starts 2 days before the onset of menses and continues through the first 3 days of menstruation. For some women with menstrual migraine, headaches that occur at this time are more severe, of longer duration, and more disabling. Although it is recognized that menstrual migraine requires specific management, there remain a number of unmet needs. In particular, comorbidity can result in women with menstrual migraine presenting to obstetrician/gynecologists or psychiatrists rather than primary care physicians or neurologists. Failure to diagnose menstrual migraine will lead to suboptimal management. Accurate diagnosis is insufficient unless it results in effective treatment strategies. Although effective and specific treatments for menstrual migraine have been developed, there is a need to define individual timing and duration of perimenstrual prophylaxis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Wober C, Brannath W, Schmidt K, et al.: Prospective analysis of factors related to migraine attacks: the PAMINA study. Cephalalgia 2007, 27:304–314.

    Article  PubMed  CAS  Google Scholar 

  2. Couturier EG, Bomhof MA, Neven AK, van Duijn NP: Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003, 23:302–308.

    Article  PubMed  CAS  Google Scholar 

  3. MacGregor EA, Igarashi H, Wilkinson M: Headaches and hormones: subjective versus objective assessment. Headache Quarterly 1997, 8:126–136.

    Google Scholar 

  4. Loder E: Migraine and menstruation. J Soc Obstet Gynaecol Can 2000, 22:512–517.

    Google Scholar 

  5. Lay CL, Payne R: Recognition and treatment of menstrual migraine. Neurologist 2007, 13:197–204.

    Article  PubMed  Google Scholar 

  6. Johannes CB, Linet MS, Stewart WF, et al.: Relationship of headache to phase of the menstrual cycle among young women: a daily diary study. Neurology 1995, 45:1076–1082.

    PubMed  CAS  Google Scholar 

  7. Dzoljic E, Sipetic S, Vlajinac H, et al.: Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University. Headache 2002, 42:185–193.

    Article  PubMed  CAS  Google Scholar 

  8. Stewart WF, Lipton RB, Chee E, et al.: Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000, 55:1517–1523.

    PubMed  CAS  Google Scholar 

  9. MacGregor EA, Hackshaw A: Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004, 63:351–353.

    PubMed  Google Scholar 

  10. Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders (2nd edition). Cephalalgia 2004, 24:1–160.

    Google Scholar 

  11. MacGregor EA, Chia H, Vohrah RC, Wilkinson M: Migraine and menstruation: a pilot study. Cephalalgia 1990, 10:305–310.

    Article  PubMed  CAS  Google Scholar 

  12. Granella F, Sances G, Zanferrari C, et al.: Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993, 33:385–389.

    Article  PubMed  CAS  Google Scholar 

  13. MacGregor EA, Brandes J, Eikermann A, Giammarco R: Impact of migraine on patients and their families: the Migraine and Zolmitriptan Evaluation (MAZE) survey—phase III. Curr Med Res Opin 2004, 20:1143–1150.

    Article  PubMed  CAS  Google Scholar 

  14. Beckham JC, Krug LM, Penzien DB, et al.: The relationship of ovarian steroids, headache activity and menstrual distress: a pilot study with female migraineurs. Headache 1992, 32:292–297.

    Article  PubMed  CAS  Google Scholar 

  15. Kibler JL, Rhudy JL, Penzien DB, et al.: Hormones, menstrual distress, and migraine across the phases of the menstrual cycle. Headache 2005, 45:1181–1189.

    Article  PubMed  Google Scholar 

  16. Granella F, Sances G, Allais G, et al.: Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004, 24:707–716.

    Article  PubMed  CAS  Google Scholar 

  17. World Health Organization: Mental Health: New Understanding, New Hope. Geneva: WHO; 2001.

    Google Scholar 

  18. Dowson AJ, Kilminster SG, Salt R, et al.: Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: a general practice study. Headache 2005, 45:274–282.

    Article  PubMed  Google Scholar 

  19. Condon JT: Premenstrual syndrome in primary care: an update. Prim Care Community Psychiatry 2006, 11:129–136.

    Article  Google Scholar 

  20. Facchinetti F: The premenstrual syndrome belongs in the diagnostic criteria for menstrual migraine. Cephalalgia 1994, 14:413–414.

    Article  PubMed  CAS  Google Scholar 

  21. Gupta VK: Menstrual migraine is not pathogenetically related to premenstrual syndrome. Cephalalgia 1994, 14:411–412.

    Article  PubMed  CAS  Google Scholar 

  22. Keenan PA, Lindamer LA: Non-migraine headache across the menstrual cycle in women with and without premenstrual syndrome. Cephalalgia 1992, 12:356–359.

    Article  PubMed  CAS  Google Scholar 

  23. Martin VT, Wernke S, Mandell K, et al.: Symptoms of premenstrual syndrome and their association with migraine headache. Headache 2006, 46:125–137.

    Article  PubMed  Google Scholar 

  24. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 15, April 2000. Premenstrual syndrome. Obstet Gynecol 2000, 95:1–9.

  25. Diagnostic and Statistical Manual of Mental Disorders, edn 4. Text Revision. Washington, DC: American Psychiatric Association; 2000.

  26. Tietjen GE, Conway A, Utley C, et al.: Migraine is associated with menorrhagia and endometriosis. Headache 2006, 46:422–428.

    Article  PubMed  Google Scholar 

  27. Tietjen GE, Brandes JL, Digre KB, et al.: High prevalence of somatic symptoms and depression in women with disabling chronic headache. Neurology 2007, 68:134–140.

    Article  PubMed  CAS  Google Scholar 

  28. Breslau N, Lipton RB, Stewart WF, et al.: Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003, 60:1308–1312.

    PubMed  CAS  Google Scholar 

  29. Molgat CV, Patten SB: Comorbidity of major depression and migraine—a Canadian population-based study. Can J Psychiatry 2005, 50:832–837.

    PubMed  Google Scholar 

  30. Lanteri-Minet M, Radat F, Chautard MH, Lucas C: Anxiety and depression associated with migraine: influence on migraine subjects’ disability and quality of life, and acute migraine management. Pain 2005, 118:319–326.

    Article  PubMed  Google Scholar 

  31. MacGregor EA, Barnes D: Migraine in a specialist menopause clinic. Climacteric 1999, 2:218–223.

    Article  PubMed  CAS  Google Scholar 

  32. Hodson J, Thompson J, al-Azzawi F: Headache at menopause and in hormone replacement therapy users. Climacteric 2000, 3:119–124.

    Article  PubMed  CAS  Google Scholar 

  33. Misakian AL, Langer RD, Bensenor IM, et al.: Postmenopausal hormone therapy and migraine headache. J Womens Health (Larchmt) 2003, 12:1027–1036.

    Article  Google Scholar 

  34. Aegidius KL, Zwart JA, Hagen K, et al.: Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study. Eur J Neurol 2007, 14:73–78.

    Article  PubMed  CAS  Google Scholar 

  35. Mueller L: Predictability of exogenous hormone effect on subgroups of migraineurs. Headache 2000, 40:189–193.

    Article  PubMed  CAS  Google Scholar 

  36. Steiner TJ, MacGregor EA, Davies PTG: Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication overuse headache (3rd edition). Available at: http://www.bash.org.uk. Accessed October 6, 2007.

  37. Mannix LK, Loder E, Nett R, et al.: Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies. Cephalalgia 2007, 27:414–421.

    Article  PubMed  CAS  Google Scholar 

  38. Loder E, Silberstein SD, Abu-Shakra S, et al.: Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study. Headache 2004, 44:120–130.

    Article  PubMed  Google Scholar 

  39. Massiou H, Pitei D, Poole P, Sikes C: Efficacy of eletriptan for the treatment of migraine in women with menstrually associated migraine, and in women on contraceptives or hormone replacement therapy: meta-analyses of randomized clinical trials. Cephalalgia 2000, 20:435.

    Article  Google Scholar 

  40. Massiou H, Jamin C, Hinzelin G, Bidaut-Mazel C: Efficacy of oral naratriptan in the treatment of menstrually related migraine. Eur J Neurol 2005, 12:774–781.

    Article  PubMed  CAS  Google Scholar 

  41. Nett R, Landy S, Shackelford S, et al.: Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. Obstet Gynecol 2003, 102:835–842.

    Article  PubMed  CAS  Google Scholar 

  42. Dowson AJ, Massiou H, Aurora SK: Managing migraine headaches experienced by patients who self-report with menstrually related migraine: a prospective, placebo-controlled study with oral sumatriptan. J Headache Pain 2005, 6:81–87.

    Article  PubMed  CAS  Google Scholar 

  43. Allais G, Acuto G, Cabarrocas X, et al.: Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci 2006, 27(Suppl 2):S193–S197.

    Article  PubMed  Google Scholar 

  44. Martin V, Cady R, Mauskop A, et al.: Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat a Migraine Early) studies. Headache 2008, 48:226–235.

    Article  PubMed  Google Scholar 

  45. Brandes JL: The influence of estrogen on migraine: a systematic review. JAMA 2006, 295:1824–1830.

    Article  PubMed  CAS  Google Scholar 

  46. Speroff L, Fritz MA: Clinical Gynecologic Endocrinology and Infertility, edn 7. Baltimore, MD: Lippincott Williams & Wilkins; 2004.

    Google Scholar 

  47. Szekely B, Botwin D, Eidelman B, et al.: Nonpharmacological treatment of menstrual headache: relaxation-biofeedback behaviour therapy and person-centred insight therapy. Headache 1986, 26:86–92.

    Article  PubMed  CAS  Google Scholar 

  48. MacGregor EA, Frith A, Ellis J, Aspinall L: Predicting menstrual migraine with a home-use fertility monitor. Neurology 2005, 64:561–563.

    PubMed  Google Scholar 

  49. MacGregor EA, Frith A, Ellis J, et al.: Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 2006, 67:2159–2163.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The City of London Migraine Clinic, 22 Charterhouse Square, London, EC1M 6DX, UK

    E. A. MacGregor

Authors
  1. E. A. MacGregor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. A. MacGregor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

MacGregor, E.A. Perimenstrual headaches: Unmet needs. Current Science Inc 12, 468–474 (2008). https://doi.org/10.1007/s11916-008-0079-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-008-0079-1

Keywords

Search

Navigation